Cannabis products high in the nonintoxicating compound CBD can quell anxiety better than THC-dominant products— and without the potential side effects, new University of Colorado Boulder research suggests.
Tag: Cannabinoid
The Medical Minute: Talk to your health care provider about any use of cannabinoid products
That CBD product might be legal, but is it safe to use with other medicine? Two Penn State Health experts agree ― talk it over with your provider.
Even Worms Get the Munchies
A study, led by University of Oregon neuroscientist Shawn Lockery, points to worms as a useful tool for understanding more about the many roles that cannabinoids naturally play in the body. And it could help researchers develop better drugs that target this system.
The body’s own cannabinoids widen the bronchial tubes
Bronchial constriction is what makes many lung diseases like asthma so dangerous. Researchers have discovered a new signalling pathway that causes the airways to widen.
Prenatal exposure to THC, CBD affects offspring’s responsiveness to Prozac
Scientists at Indiana University have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice’s ability as adults to respond to fluoxetine, a drug commonly known by the brand name Prozac.
Toxicologists to Showcase Latest Science Affecting Public, Animal, and Environmental Health during SOT Annual Meeting and ToxExpo
With more than 65 Featured and Scientific Sessions and 1,000+ presentations showcasing advances in fundamental and translational sciences and emerging disciplines and technologies, the Virtual 2021 Annual Meeting and ToxExpo of the Society of Toxicology (SOT) is the largest forum for toxicological research in the world.
Certain CBD oils no better than pure CBD at inhibiting certain cancer cell lines
Cannabidiol (CBD) oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, according to Penn State College of Medicine researchers.
Researcher receives $3.9 million grant to study how cannabis chemicals can help with pain
Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.
Scientists receive NIH grant to support study using THC as therapy for HIV patients suffering from inflammation
More than $3.7 million was awarded to Mahesh Mohan, DVM, MS, Ph.D., Professor at the Texas Biomedical Research Institute, and Chioma M. Okeoma, Ph.D., Associate Professor at Stony Brook University, to explore the link between cannabinoids (THC) and chronic intestinal inflammation in patients infected with the human immunodeficiency virus (HIV).